{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:06Z","timestamp":1786994406687,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.msard.2022.104232","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T11:16:45Z","timestamp":1665227805000},"page":"104232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Theranostic potential of graphene quantum dots for multiple sclerosis"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-6123","authenticated-orcid":false,"given":"Birsen Can","family":"Demird\u00f6\u011fen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.104232_bib0001","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IJN.S357980","article-title":"Biomedical applications of quantum dots: overview, challenges, and clinical potential","volume":"17","author":"Abdellatif","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.msard.2022.104232_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jssc.2019.121107","article-title":"Photodynamic therapy using graphene quantum dot derivatives","volume":"282","author":"Ahirwar","year":"2020","journal-title":"J. Solid State Chem."},{"key":"10.1016\/j.msard.2022.104232_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060338","article-title":"Promising nanotechnology approaches in treatment of autoimmune diseases of central nervous system","volume":"10","author":"Chountoulesi","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2022.104232_bib0004","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.msard.2022.104232_bib0005","doi-asserted-by":"crossref","unstructured":"Ghalamfarsa, G., Hojjat-Farsangi, M., Mohammadnia-Afrouzi, M., Anvari, E., Farhadi, S., Yousefi, M., Jadidi-Niaragh, F., 2016. Application of nanomedicine for crossing the blood\u2013brain barrier: theranostic opportunities in multiple sclerosis. J. Immunotoxicol. 13, 603\u2013619. 10.3109\/1547691X.2016.1159264.","DOI":"10.3109\/1547691X.2016.1159264"},{"key":"10.1016\/j.msard.2022.104232_bib0006","article-title":"Near-infrared emitting graphene quantum dots synthesized from reduced graphene oxide for in vitro\/in vivo\/ex vivo bioimaging applications","volume":"8","author":"Hasan","year":"2021","journal-title":"TDM"},{"key":"10.1016\/j.msard.2022.104232_bib0007","doi-asserted-by":"crossref","DOI":"10.5812\/thrita.100105","article-title":"Quantum dots application in neurodegenerative diseases","volume":"9","author":"Hasannejadasl","year":"2021","journal-title":"Thrita"},{"key":"10.1016\/j.msard.2022.104232_bib0008","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1039\/C4TB01650E","article-title":"Application of paramagnetic graphene quantum dots as a platform for simultaneous dual-modality bioimaging and tumor-targeted drug delivery","volume":"3","author":"Huang","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.msard.2022.104232_bib0009","first-page":"451","article-title":"Transcutaneous photodynamic therapy delays the onset of paralysis in a murine multiple sclerosis model","volume":"2371","author":"Hunt","year":"1995","journal-title":"SPIE"},{"key":"10.1016\/j.msard.2022.104232_bib0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acschemneuro.6b00428","article-title":"Enhanced brain delivery of dimethyl fumarate employing tocopherol-acetate-based nanolipidic carriers: evidence from pharmacokinetic, biodistribution, and cellular uptake studies","volume":"8","author":"Kumar","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.msard.2022.104232_bib0011","unstructured":"Naumov, AV., Hasan, T., inventors. (2021). Near-infrared emissive graphene quantum dots method of manufacture and uses thereof. U.S. Patent and Trademark Office. Published as: US2021269711A1. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/077464309\/publication\/US2021269711A1?q=ia%20all%20%22tanvir%20hasan%22%20AND%20ta%20all%20%22GRAPHENE%22%20AND%20ctxt%20all%20%22quantum%20dots%22%20AND%20ctxt%20all%20%22near-infrared%22."},{"key":"10.1016\/j.msard.2022.104232_bib0012","first-page":"12","article-title":"Near-infrared fluorescence imaging in humans with indocyanine green: a review and update","volume":"2","author":"Marshall","year":"2020","journal-title":"Open Surg. Oncol. J."},{"key":"10.1016\/j.msard.2022.104232_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103712","article-title":"Unravelling the potential of graphene quantum dots in biomedicine and neuroscience","author":"Perini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2022.104232_bib0014","doi-asserted-by":"crossref","unstructured":"Rojas, J.C., Lee, J., John, J.M., Gonzalez-Lima, F., 2008. Neurobiology of disease neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy. 10.1523\/JNEUROSCI.3457-08.2008.","DOI":"10.1523\/JNEUROSCI.3457-08.2008"},{"key":"10.1016\/j.msard.2022.104232_bib0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/awg176","article-title":"Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis","volume":"126","author":"Schmidt","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.104232_bib0016","first-page":"1","article-title":"Nanomedicine and tissue engineering","author":"Sudhakar","year":"2015","journal-title":"Nanotechnol. Appl. Tissue Eng."},{"key":"10.1016\/j.msard.2022.104232_bib0017","doi-asserted-by":"crossref","unstructured":"Sun, Y., Zheng, Y., Pan, H., Chen, J., Zhang, W., Fu, L., Zhang, K., Tang, N., Du, Y., 2017. ARTICLE Magnetism of graphene quantum dots 2, 5. 10.1038\/s41535-017-0010-2.","DOI":"10.1038\/s41535-017-0010-2"},{"key":"10.1016\/j.msard.2022.104232_bib0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jphotobiol.2017.04.014","article-title":"Biological effects and medical applications of infrared radiation HHS public access","volume":"170","author":"Tsai","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.msard.2022.104232_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2018.11.023","article-title":"A systematic review of the use of near-infrared fluorescence imaging in patients with peripheral artery disease","volume":"70","author":"van den Hoven","year":"2019","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.msard.2022.104232_bib0020","first-page":"382","article-title":"Far infrared ray radiation inhibits the proliferation of A549, HSC3 and Sa3 cancer cells through enhancing the expression of ATF3 gene","volume":"2010","author":"Yamashita","year":"2010","journal-title":"J. Electromagn. Anal. Appl."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822007374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:02:42Z","timestamp":1761901362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822007374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"alternative-id":["S2211034822007374"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104232","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theranostic potential of graphene quantum dots for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104232"}}